[1] 朱立国,姜洁,宋词,等. 江苏省2012-2014年HBV携带者进展为慢性乙型肝炎患者的队列特征分析.中华流行病学杂志,2016,37(11):1463-1467.
[2] Layek B,Lipp L,Singh J.APC targetedmicelle for enhanced intradermal delivery of hepatitis B DNA vaccine. J Control Release,2015,10(207):143-153.
[3] 陆建国. 聚乙二醇干扰素α-2a联合乙肝疫苗治疗慢性乙型肝炎疗效观察.实用肝脏病杂志,2014,17(1):34-36.
[4] Xie YD,Ma H,Feng B,et al.Efficacy of real-world entecavir therapy in treatment-naive chronic hepatitis B patients.Chin Med J (Engl),2017,130(18):2190-2197.
[5] 王永梅,曲熙波,郝淑卿,等.延续性护理对慢性乙型肝炎患者治疗依从性和治疗效果的影响.中国健康教育,2016,32(2):169-170,180.
[6] Wai CT,Wong ML,Ng S,et al.Utility of the health belief model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther,2005,21(10):1255-1262.
[7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):V-XXⅢ.
[8] 苏春雄,杜丽群,黄金萍,等. 护理干预对艾滋病住院患者抗病毒治疗依从性的效果评价. 现代医药卫生,2012,28(1):30-31.
[9] Newnham EA,Harwood KE,Page AC.Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disord,2007,98(1-2):91-97.
[10] 温馨,轧春妹,王佩,等.授权教育对慢性乙型肝炎患者生存质量的影响. 解放军护理杂志,2016,33(2):65-68.
[11] Thariat J,Creisson A,Chamignon B,et al.Integrating patient education in your oncology practice. Bull Cancer,2016,103(7-8):674-90.
[12] 黄丹. 护理干预对病毒性肝炎患者治疗依从性及 SAS、SDS 评定的影响分析.中国基层医药,2014,5(12):796-797. |
